Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-24 @ 10:46 PM
NCT ID:
NCT06271369
Eligibility Criteria:
Inclusion Criteria:
* Patients had at least one International Classification of Diseases, 10th Revision (ICD-10) diagnosis code for DLBCL.
* Patients received CAR-T therapy, including both tisa-cel and axi-cel, following DLBCL diagnosis. The administration date of CAR-T therapy was defined as the index date.
* Patients were at least 18 years of age as of the index date.
* Patients had at least three months of continuous health plan enrollment before the index date.
Exclusion Criteria:
* Patients who had a medical claim associated with a clinical trial within one month before and after the index date.
* Patients who had zero cost on index date for CAR-T infusion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06271369
Study Brief:
Protocol Section:
NCT06271369